Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.55 |
| ▸ | CHUK | O15111 | 1/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 10/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | KDM5A | P29375 | 1/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.40 |
| ▸ | GSK3A | P49840 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30356278 | 0.88 | CHUK (0.55) | KIF11CHUKTRPV1METAP2EPHX2 | |
| SCHEMBL12473661 | 0.83 | BACE1 (0.48) | KIF11BACE1METAP2 | |
| SCHEMBL12310186 | 0.83 | BACE1 (0.48) | KIF11BACE1METAP2 | |
| SCHEMBL12320899 | 0.83 | BACE1 (0.48) | KIF11BACE1METAP2 | |
| SCHEMBL25625862 | 0.83 | TRPV1 (0.41) | KIF11TRPV1GSK3AGSK3BCDK5 | |
| SCHEMBL31478776 | 0.82 | KIF11 (0.49) | KIF11CHUKBACE1METAP2 | |
| SCHEMBL9998096 | 0.82 | KIF11 (0.49) | KIF11CHUKBACE1METAP2 | |
| SCHEMBL11139756 | 0.82 | KIF11 (0.49) | KIF11CHUKBACE1METAP2 | |
| SCHEMBL29963616 | 0.82 | KIF11 (0.49) | KIF11CHUKBACE1METAP2 | |
| SCHEMBL12317668 | 0.79 | BACE1 (0.46) | KIF11BACE1METAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192719-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192719-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | OR10J3, CRY1, RPS19 | KIF11 3790/4885CHUK 3067/4885TRPV1 1972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.